Bupropion for smoking cessation: from the rationale to the quantitative aspects of the results.
Van Meerhaeghe
A
A
Department of Respiratory diseases, CHU A. Vesale, Montigny-le-Tilleul, Belgium. avanmeerhaeghe@chuvesale.be
D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects / Q000627:therapeutic use*; D016642:Bupropion / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D016540:Smoking Cessation / Q000379:methods* / Q000523:psychology
D018687:Antidepressive Agents, Second-Generation; D016642:Bupropion